Skip to content

Clinical trials

Malaria, Falciparum trials in Burkina Faso

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Malaria, Falciparum Country / region: Burkina Faso Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20073
20083
20101
20112
20133
20144
20161
20172
20191
20204
20213
20221
20234
20243
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting7
Active, not recruiting4
Terminated2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
University of Oxford7
GlaxoSmithKline6
London School of Hygiene and Tropical Medicine5
Medicines for Malaria Venture3
Sanaria Inc.3
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2
Centre MURAZ/Institut National de Santé Publique1
Centre national de recherche et de formation sur le paludisme1
Clinton Health Access Initiative Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Malaria, Falciparum51
Malaria27
Anemia2
Asymptomatic Infections1
Birth Weight1
Death1
Elimination Disorders1
Hepatitis B1
Lymphoma, Follicular1
Malnutrition1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.